Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Cue Biopharma Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cue Biopharma Inc. April 13, 202669.0%
-
Cue Biopharma Inc. June 4, 202577.9%
-
Cue Biopharma Inc. June 5, 202465.2%
-
Cue Biopharma Inc. June 7, 202383.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 2023 | Cue Biopharma Inc. | Option exercise | +9,682 | $2.86 | $27,691 |
| Mar 23, 2023 | Cue Biopharma Inc. | Open-market sale | −9,325 | $3.28 | $30,586 |
Questions about Peter A. Kiener
What boards is Peter A. Kiener on?
Peter A. Kiener sits on the boards of Cue Biopharma Inc. and Palvella Therapeutics Inc.
How long has Peter A. Kiener served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.